|
|
Gastroenterology, Hepatology and Nutrition
Research Funding
(listed alphabetically by Principal Investigator or by Section faculty member involved)
2006-2008
Determination of Pathogenetic Mechanisms of Eosinophilic Esophagitis
Principal Investigator: Glenn T. Furuta, MD
Source: CURED (Campaign Urging Research for Eosinophilic Disease) Foundation
Amount: $100,000/yr
Term: 2008 - 2009
Esophageal Fibrosis in Patients with Eosinophilic Esophagitis
Principal Investigators: Glenn T. Furuta, MD, and Steven J. Ackerman, PhD
Source: American Gastroenterological Association
Amount: $100,000/yr
Term: 2008 - 2010
Improving Lives of Patients with Eosinophilic Esophagitis
Principal Investigators: Glenn T. Furuta, MD, Rachel Rosen, MD, and Samuel Nurko, MD
Source: Pappas Foundation
Amount: $60,000
Term: 2006 - 2009
The International Gastrointestinal Eosinophil Research Consortium
Principal Investigator: Glenn T. Furuta, MD
Source: Food Allergy Project
Amount: $330,000/yr
Term: 2008 - 2011
Natural History of Eosinophilic Esophagitis
Principal Investigator: Glenn T. Furuta, MD
Source: Pappas Foundation
Amount: $20,000/yr
Term: 2009
Novel Assessment of Esophageal Disease
Principal Investigators: Glenn T. Furuta, MD, and Steven J. Ackerman, PhD
Source: NIAID, NIH - R21-AI079925
Amount: $125,000/yr
Term: 2008 - 2010
Role of Eosinophils in Esophageal Dysfunction
Principal Investigator: Glenn T. Furuta, MD
Source: NIDDK, NIH - 7 R01 DK062245-03
Amount: $312,422/yr
Term: 2004 - 2009
Autism Treatment Network
Principal Investigator: Ann M. Reynolds, MD
Co-Investigator: Glenn T. Furuta, MD
Source: Autism Treatment Network
Amount: $3,400/yr
Term: 2008 - 2009
A Multicenter, Double-Blind Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Crohn’s Disease
Principal Investigator: Edward J. Hoffenberg, MD
Source: Abbott Laboratories
Amount: Per patient
Term: 2008 - ongoing
A Multicenter, Prospective, Long-Term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease
Principal Investigator: Edward J. Hoffenberg, MD
Source: Johnson & Johnson
Amount: Per patient
Term: 2008 - ongoing
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian J. Rewers, MD, PhD, MPH
Co-Investigators: Edward J. Hoffenberg, MD, and Ronald J. Sokol, MD
Source: NIH - R01 DK50979-06A1
Amount: $1,436,790
Term: 2002 - 2006
Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: NIH - 1 U19 AI50864-01 (Revised)
Amount: $2,679,247
Term: 2001 - 2006
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jane Keng, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2004 - 2006
An Efficacy and Safety Study of Reslizumab (CTX55700) in the Treatment of Eosinophilic Esophagitis in Subjects Aged 5 to 18 years
Principal Investigator: Robert E. Kramer, MD
Source: Ception Therapeutics, Inc
Amount: $10,396/yr
Term: 2008 - 2010
Altering the PL of Peptide Vaccines to Avoid Anaphylaxis
Principal Investigator: Edwin Liu, MD
Source: NIDDK, NIH - K08 DK064605-01
Amount: $118,950/yr
Term: 2003 - 2008
Autoimmunity Prevention Centers Pilot Project Award
Principal Investigator: Edwin Liu, MD
Source: NIH Autoimmunity Prevention Center
Amount: $75,000/yr
Term: 2007 - 2008
Autoimmunity Prevention Center U-01 Pilot Award
Consultant: Edwin Liu, MD
Source: NIH Autoimmunity Prevention Center
Amount: $25,000/yr
Term: 2007 - 2008
Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: NIDDK, NIH - K08 DK60710-01
Amount: $625,000
Term: 2002 - 2006
Investigation of Pathogenic Autoreactive T Cells in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: American Liver Foundation - PN200509-244
Amount: $100,000
Term: 2006 - 2008
Perturbation of Regulatory T Cells in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: American Gastroenterolgical Association
Amount: $25,000/yr
Term: 2008 - 2009
Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: March of Dimes Birth Defects Foundation
Amount: $150,000
Term: 2005 - 2007
Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: NIDDK, NIH - RO3 DK069818-01
Amount: $100,000
Term: 2004 - 2006
T Cell-Mediated Mechanisms of Autoimmunity in Murine and Human Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: NIDDK, NIH - 1 R01 DK078195-01A1
Amount: $272,953
Term: 2007 - 2012
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Vincent Mukkada, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2005 - 2007
Longitudinal Study of Cystic Fibrosis-Associated Liver Disease
Principal Investigator: Michael R. Narkewicz, MD
Source: Cystic Fibrosis Foundation
Amount: $500,000/yr
Term: 2008 - 2009
Long-Term Follow-Up Protocol to Assess Pediatric Subjects After Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001 - 2007
A Multicenter Group to Study Acute Liver Failure in Children
Principal Investigator: Robert Squires MD
Co-Investigators: Michael R. Narkewicz MD, and Ronald J. Sokol, MD
Source: NIDDKD, NIH - U01 DK072146-01
Amount: $25,000/yr (Denver)
Term: 2005 - 2010
Pegylated Interferon +/- Ribavirin for Children with HCV: Randomized Placebo-Controlled Trial of Pegylated Interferon With or Without Ribavirin
Principal Investigator: Kathleen Schwarz, MD
Investigator: Michael R. Narkewicz, MD
Source: NIDDK, NIH - U01 DK067767
Amount: $18,000/yr (Denver)
Term: 2004 - 2010
Studies of Pediatric Liver Transplantation
Principal Investigator: Anne Lindblad, PhD
Co-Investigators: Michael R. Narkewicz, MD, Shikha S. Sundaram, MD, MSCI, and Ronald J. Sokol, MD
Source: NIDDKD, NIH - 1 U01 DK061693-01A1
Amount: $940,000/yr
Term: 2004 - 2009
Study of a New Method of Assessment of Fat Malabsorption in Cystic Fibrosis
Principal Investigator: James Heubi MD (Cincinnati)
Investigator: Michael R. Narkewicz, MD
Source: Cystic Fibrosis Foundation
Amount: $15,000/yr
Term: 2007 - 2008
Pediatric Intestinal Failure Consortium
Principal Investigator: Robert Squires, MD
Investigator: Jason Soden, MD
Source: NIDDK, NIH
Amount: $5,428
Term: 2008 - 2009
Cholestatic Liver Disease Consortium Support
Principal Investigator: Ronald J. Sokol, MD
Source: Alpha One Foundation
Amount: $50,000/yr
Term: 2006 - 2011
Colorado Clinical and Translational Sciences Institute
Principal Investigator: Ronald J. Sokol, MD
Co-Directors: William W. Hay, Jr., MD, Michael G. Kahn, MD, PhD, Robert H. Eckel, MD, Mark W. Geraci, MD, Marc Moss, MD, and Andrew Kramer, MD
Source: NCRR, NIH - UL1 RR025780, KL1RR025779, TL1 RR 025778
Amount: $76,155,655
Term: 2008 - 2013
Pediatric Clinical Translational Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Directors: William W. Hay, Jr., MD, and Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: NIH, NCRR - MO1 RR00069
Amount: $19,434,966
Term: 2006 - 2008
Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Co-Investigators: Cara L. Mack, MD, Michael R. Narkewicz, MD, Shikha S. Sundaram, MD, MSCI, Frederick Karrer, MD, and Mark Lovell, MD
Source: NIDDK, NIH - 1 U01-DK062453
Amount: $486,984/yr
Term: 2002 - 2009
Institutional Training Grant - Pediatric Gastroenterology
Principal Investigator: Ronald J. Sokol, MD
Co-Investigator: Michael R. Narkewicz, MD
Source: NIDDKD, NIH - 1 T32 DK067009-01
Amount: $243,825/yr
Term: 2005 - 2010
Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: NIH - DK38446-09
Amount: $1,595,198
Term: 2001 - 2006
Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Co-Investigators: Cara L. Mack, MD, Michael R. Narkewicz, MD, Shikha S. Sundaram, MD, MSCI, and Johan L. Van Hove, MD, PhD
Source: NIDDK, NCRR, ORD, NIH - 1 U54 DK 078377
Amount: $728,251/yr
Term: 2004 - 2009
Supply Agreement with Mead Johnson Nutritionals, Inc., for Pregestamil infant Formula for 140 Infants in Biliary Atresia Research Consortium Study, Steroids in Biliary Atresia Randomized Trial
Principal Investigator: Ronald J. Sokol, MD
Source: Mead Johnson Nutritionals, Inc.
Amount: $10,000/yr
Term: 2005 - 2009
Functional Outcomes in Pediatric Liver Transplantation
Principal Investigator: Estella Alonso, MD
Co-Investigator: Ronald J. Sokol, MD
Source: NICHD, NIH - 1 R01 HD045694
Amount: $421,088/yr
Term: 2005 - 2010
First- and Second-Year Clinical Fellowship (Jillian Sullivan, MD)
Principal Investigator: Jillian Sullivan, MD
Source: Cystic Fibrosis Foundation
Amount: $47,000/yr
Term: 2008 - 2010
Isoprostanes: A Marker of Oxidative Injury in Non-Alcoholic Fatty Liver
Principal Investigator: Shikha S. Sundaram, MD, MSCI
Source: TCH Research Institute Pilot Award
Amount: $36,000/yr
Term: 2008 - 2009
Isoprostanes: A Marker of Oxidative Injury in Non-Alcoholic Fatty Liver
Principal Investigator: Shikha S. Sundaram, MD, MSCI
Source: TCH CTRC Pilot and Feasibility Award
Amount: $25,000/yr
Term: 2008 - 2009
Studies of Primary Sclerosing Cholangitis (STOP-SC)
Principal Investigator: Shikha S. Sundaram, MD, MSCI
Source: Morgan Foundation
Amount: $10,000/yr
Term: 2008 - 2013
First- and Second-Year Clinical Fellowship (Christine Waasdorp, MD)
Principal Investigator: Christine Waasdorp, MD
Source: Cystic Fibrosis Foundation - WAASDO07B0
Amount: $91,750
Term: 2007 - 2009
First- and Second-Year Clinical Fellowship (Samantha Woodruff, MD)
Principal Investigator: Samantha Woodruff, MD
Source: Cystic Fibrosis Foundation - WOODRU06B0
Amount: $85,250
Term: 2006 - 2008
2005
Training Grant for Gastrointestinal Diseases
Program Director: Dennis Ahnen, MD
Trainee: Adria A. Condino, DO
Source: National Institutes of Health - T32 DK07038
Amount: $207,980
Term: 2000-2005
Training Grant for Gastrointestinal Diseases
Program Director: Dennis Ahnen, MD
Trainee: John Whitworth, MD
Source: National Institutes of Health - T32 DK07038
Amount: $207,980
Term: 2000-2006
Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - 1 U19 AI50864-01 (Revised)
Amount: $2,679,247
Term: 2001-2006
Pediatric Clinical Translational Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Director: William W. Hay, Jr., MD
Associate Program Director: Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: National Institutes of Health, National Center for Research Resources - MO1 RR00069
Amount: $16,884,197
Term: 2001-2006
Multicenter Group to Study Acute Liver Failure
Principal Investigator: William Lee, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK58369
Amount: $2,278,420
Term: 2000-2005
Altering the Pl of Peptide Vaccines to Avoid Anaphylaxis
Principal Investigator: Edwin Liu, MD
Source: National Institutes of Health - K08 DK064605-01
Amount: $610,490
Term: 2003-2008
Defining the Potential Role of Costimulation by Enterocytes in Celiac Disease
Principal Investigator: Edwin Liu, MD
Source: GlaxoSmithKline and Institute of Digestive Health GIDH Basic Research Award
Amount: $50,000
Term: 2000-2005
Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - K08 DK60710-01
Amount: $625,000
Term: 2002-2006
Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - RO3 DK069818-01
Amount: $100,000
Term: 2004-2006
Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: March of Dimes Birth Defects Foundation
Amount: $150,000
Term: 2005-2007
Long-Term Follow-Up Protocol to Assess Pediatric Subjects after Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001-2007
Pegylated Interferon +/- Ribavirin for Children with HCV
Principal Investigator: Kathy Schwarz, MD
MultiCenter Trial Principal Investigator (Denver): Michael R. Narkewicz, MD
Source: National Institutes of Health - U01 DK067767
Amount: $18,000/yr (Denver)
Term: 2004-2009
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - R01 DK50979-06A1
Amount: $1,436,790
Term: 2002-2006
Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - U54 RR019455
Amount: $3,750,000
Term: 2004-2009
Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK38446-09
Amount: $1,595,198
Term: 2001-2006
Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 UO1-DK062453-01
Amount: $1,586,366
Term: 2002-2009
A Preliminary Clinical Research Study on Antioxidant Therapy for Biliary Atresia in Infants and Children
Principal Investigator: Ronald J. Sokol, MD
Source: Madigan Foundation
Amount: $22,750
Term: 2002-2005
Studies in Pediatric Liver Transplantation
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - U01 DK061693
Amount: $4,700,000
Term: 2004-2009
A Multicenter Group to Study Acute Liver Failure in Children
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - U01 DK072146
Amount: $25,000/yr
Term: 2005-2010
Functional Outcomes in Pediatric Liver Transplantation
Principal Investigator: Robert Squires, MD
Local Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - R01 HD045694
Amount: $2,247,040
Term: 2005-2010
Studies in Pediatric Liver Transplantation
Principal Investigator: Ronald J. Sokol, MD
Source: Fugisawa, Roche Laboratories
Amount: $4,000/yr
Term: 1995-present
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jason S. Soden, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2003-2005
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jane Keng, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2004-2006
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Vincent Mukkada, MD
Source: Cystic Fibrosis Foundation
Amount: $85,750
Term: 2005-2007
Institutional Training Grant - Pediatric Gastroenterology
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 T32 DK06709
Amount: $1,082,424
Term: 2005
2003-2004
Training Grant for Gastrointestinal Diseases
Program Director: Dennis Ahnen, MD
Trainee: Adria A. Condino, DO
Source: National Institutes of Health - T32 DK07038
Amount: $207,980
Term: 2000-2005
Regulation of Biliary Secretion by Purinergic Signaling
Principal Investigator: Andrew P. Feranchak, MD
Source: National Institutes of Health - K08 DK61480
Amount: $653,400
Term: 2002-2007
Calcium-Dependent Secretion In Biliary Epithelium
Principal Investigator: Andrew P. Feranchak, MD
Source: Cystic Fibrosis Foundation
Amount: $64,695
Term: 2004-2005
Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - 1 U19 AI50864-01
Amount: $2,679,247
Term: 2001-2006
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PHD, MPH
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - R01 DK50979-06A1
Amount: $1,436,790
Term: 2002-2006
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jane A. Keng, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2004-2006
Altering the Pl of Peptide Vaccines to Avoid Anaphylaxis
Principal Investigator: Edwin Liu, MD
Source: National Institutes of Health - K08 DK064605-01
Amount: $610,490
Term: 2003-2008
Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - K08 DK60710-01
Amount: $625,000
Term: 2002-2006
Role of Cytokines and Autoimmunity in Murine Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health - R03 DK069818-01
Amount: $100,000
Term: 2004-2006
Long-Term Follow-Up Protocol to Assess Pediatric Subjects after Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001-2007
Pegylated Interferon +/- Ribavirin for Children with HCV (Multicenter Trial)
Principal Investigator: Kathy Schwarz, MD
Co-Principal Investigator: Michael R. Narkewicz, MD
Source: National Institutes of Health - U01 DK067767
Amount: $18,000/yr
Term: 2004-2009
Evaluation of Infantile Gastroesophageal Reflux Utilizing pH-Impedance Monitoring
Principal Investigator: Judith A. O'Connor, MD
Source: Pediatric General Clinical Research Center, National Center for Research Resources, National Institutes of Health - M01-RR00069
Term: 2003-2005
Frequency of ASCA Seropositivity in Children with Cystic Fibrosis
Principal Investigator: Judith A. O'Connor, MD
Source: General Clinical Research Center, National Center for Research Resources, National Institutes of Health - M01-RR00069
Term: 2003-2004
Cystic Fibrosis Foundation First- and Second-Year Fellowship Training Award
Principal Investigator: Jason S. Soden, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2003-2005
Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Co-Investigator: Johan Van Hove, MD, PhD
Source: National Institutes of Health - U54 RR019455
Amount: $4,700,000
Term: 2004-2009
Pediatric General Clinical Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Director: William W. Hay, Jr., MD
Associate Program Director: Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: National Institutes of Health, National Center for Research Resources - MO1 RR00069
Amount: $16,884,197
Term: 2001-2006
Multicenter Group to Study Acute Liver Failure
Principal Investigator: William Lee, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK58369
Amount: $2,278,420
Term: 2000-2005
Nutritional Etiology of Prediabetic Autoimmunity
Principal Investigator: Jill Norris, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - K0849654
Amount: $2,008,009
Term: 2001-2005
Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK38446-09
Amount: $1,595,198
Term: 1997-2006
Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 UO1-DK062453-01
Amount: $854,945
Term: 2002-2007
Third-Year Research Fellowship Award
Program Director: Ronald J. Sokol, MD
Fellow: Gregory E. Kobak, MD
Source: Cystic Fibrosis Foundation
Amount: $62,590
Term: 2002-2003
First- and Second-Year Clinical Fellowship Award
Program Director/Sponsor: Ronald J. Sokol, MD
Fellow: Elizabeth Utterson, MD
Source: Cystic Fibrosis Foundation - COLSON02BO
Amount: $42,000
Term: 2002-2003
A Preliminary Clinical Research Study on Antioxidant Therapy for Biliary Atresia in Infants and Children
Principal Investigator: Ronald J. Sokol, MD
Source: Madigan Foundation
Amount: $22,750
Term: 2003-2005
Postdoctoral Research Fellowship Grant
Program Director/Sponsor: Ronald J. Sokol, MD
Fellow: Gregory E. Kobak, MD
Source: American Liver Foundation
Amount: $10,000
Term: 2002-2003
Studies in Pediatric Liver Transplantation
Principal Investigator: Ronald J. Sokol, MD
Source: Fujisawa, Roche Laboratories
Amount: $4,000/yr
Term: 2004-2009
2001-2002
Virginia Mason/UCD Autoimmune Prevention Center
Principal Investigator: George S. Eisenbarth, MD, PhD
Co-Investigator: Edward J. Hoffenberg, MD
Source: National Institutes of Health - 1 U19 AI50864-01 (Revised)
Amount: $2,679,247
Term: 2001-2006
The NASPGHAN Children's Digestive Health and Nutrition Young Investigator Award
Principal Investigator: Andrew P. Feranchak, MD
Source: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
Amount: $60,000
Term: 1999-2002
Regulation of Hepatocyte Cell Volume by Nonselective Cation Channels
Principal Investigator: Andrew P. Feranchak, MD
Source: American Gastroenterologic Association, American Digestive Health Foundation
Amount: $150,000
Term: 1999-2003
Regulation of Biliary Secretion by Purinergic Signaling
Principal Investigator: Andrew P. Feranchak, MD
Source: National Institutes of Health - K08 DK61480
Amount: $500,000
Term: 2002-2007
Celiac Disease in Type 1 Diabetes: Growth and Bone Mineralization
Principal Investigator: Edward J. Hoffenberg, MD
Source: Genentech, Inc.
Amount: $28,000
Term: 2002
Pediatric General Clinical Research Center
Principal Investigator: Richard D. Krugman, MD
Program Director: Ronald J. Sokol, MD
Associate Program Director: William W. Hay, Jr., MD
Associate Program Director: Philip S. Zeitler, MD, PhD
Assistant Program Director: Nancy F. Krebs, MD
Source: National Institutes of Health, National Center for Research Resources - MO1 RR00069
Amount: $16,752,400
Term: 2001-2006
Multicenter Group to Study Acute Liver Failure
Principal Investigator: William Lee, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK58369
Amount: $2,278,420
Term: 2000-2005
Immunologic Mechanisms of Biliary Destruction in Biliary Atresia
Principal Investigator: Cara L. Mack, MD
Source: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases - K08 DK60710-01
Amount: $625,000
Term: 2002-2006
Ontogeny of Fetal Hepatic Serine and Glycine Metabolism
Principal Investigator: Michael R. Narkewicz, MD
Source: National Institute of Child Health and Development FIRST Award
Amount: $350,000
Term: 1995-2001
Pharmacokinetics of Interferon and Ribavirin in the Treatment of Chronic Hepatitis C in Children
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P00017-00018 (Multicenter, Multinational Study)
Amount: $60,000
Term: 1999-2001
The Safety and Efficacy of Interferon and Ribavirin in the Treatment of Chronic Hepatitis C in Children
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P00017-00032 (Multicenter, Multinational Study)
Amount: $15,000
Term: 1999-2001
Bridge Funding: Regulation of Fetal Hepatic Folate Metabolism
Principal Investigator: Michael R. Narkewicz, MD
Source: The Children's Hospital Research Institute
Amount: $51,144
Term: 2000-2002
The Safety, Viral Kinetics and Pharmacokinetics of PegasysTM After Multiple Doses in Young Children with Chronic Hepatitis C Infection
Local Principal Investigator: Michael R. Narkewicz, MD
Source: F. Hoffmann-La Roche Ltd - NR 16141 (Multicenter, Multinational Study)
Amount: $7,500
Term: 2000-2001
Long-Term Follow-Up Protocol to Assess Pediatric Subjects after Completing 24 Weeks of Follow-Up in SPRI Clinical Trial for Chronic Hepatitis C
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P01906 (Multicenter, Multinational Study)
Amount: $12,000
Term: 2001-2007
Nutritional Etiology of Prediabetic Autoimmunity
Principal Investigator: Jill Norris, PhD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK49654-01
Amount: $2,008,009
Term: 1997-2001
Tauro-Ursodeoxycholic Acid for the Treatment of Hepatobiliary Disease in Cystic Fibrosis
Principal Investigator: Kenneth Setchell, PhD
Site Director: Michael R. Narkewicz, MD
Source: Federal Drug Administration
Amount: $5,027
Term: 1997-2002
Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK38446-09
Amount: $1,006,612
Term: 1997-2006
An Extended, Stratified, Follow-On Study in Pediatric Subjects with Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies
Local Principal Investigator: Ronald J. Sokol, MD
Source: GlaxoSmithKline - NUC30926
Amount: $13,000
Term: 1999-2001
Second-Year Clinical Fellowship Grant for Edwin Liu, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $40,000
Term: 2000-2001
Second-Year Clinical Fellowship Grant for Gregory Kobak, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $36,000
Term: 2001-2002
First- and Second-Year Clinical Fellowship Grant for Elizabeth Colson (Utterson), MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $42,000
Term: 2002-2003
Postdoctoral Research Fellow Grant for Gregory Kobak, MD
Principal Investigator: Ronald J. Sokol, MD
Source: American Liver Foundation
Amount: $10,000
Term: 2002-2003
Third-Year Research Fellowship Grant for Gregory Kobak, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $62,590
Term: 2002-2003
Etiology and Treatment of Biliary Atresia and Idiopathic Neonatal Hepatitis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - 1 UO1-DK062453-01
Amount: $854,945
Term: 2002-2007
1999-2000
Safety and Efficacy of Exisulind in Children and Adolescents with Familial Polyposis Coli and Intact Colons
Principal Investigator: Edward J. Hoffenberg, MD
Source: Cell Pathways, Inc.
Amount: $155,636
Term: 1999-2000
The Pathogenesis of Neonatal Cholestatic Liver Disease
Principal Investigator: Lela Lee, MD
Co-Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK53754
Amount: $147,642/yr
Term: 1997-1999
A Multicenter Group to Study Acute Liver Failure
Principal Investigator: William Lee, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK58369
Amount: $2,278,420
Term: 2000-2005
Ontogeny of Fetal Hepatic Serine and Glycine Metabolism
Principal Investigator: Michael R. Narkewicz, MD
Source: National Institute of Child Health and Development FIRST Award
Amount: $350,000
Term: 1995-2001
Bridge Funding
Principal Investigator: Michael R. Narkewicz, MD
Source: The Children's Hospital Research Foundation
Amount: $51,000
Term: August 2000-July 2001
Pharmacokinetics of Interferon and Ribavirin in the Treatment of Chronic Hepatitis C in Children
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough - P00017-00018 (Multicenter, Multinational Study)
Amount: $60,000
Term: 1999-2001
Safety and Efficacy of Interferon and Ribavirin in the Treatment of Chronic Hepatitis C in Children
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Schering Plough P00017-00032 (Multicenter, Multinational Study)
Amount: $15,000
Term: 1999-2001
The Safety, Viral Kinetics and Pharmacokinetics of PegasysTM after Multiple Doses in Young Children with Chronic Hepatitis C Infection
Local Principal Investigator: Michael R. Narkewicz, MD
Source: Roche NR 16141 (Multicenter, Multinational Study)
Amount: $7,500
Term: 2000-2001
Nutritional Etiology of Prediabetic Autoimmunity
Principal Investigator: Jill Norris, PhD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK49654-01
Amount: $2,008,009
Term: 1997-2001
Genetic and Environmental Causes of Celiac Disease
Principal Investigator: Marian Rewers, MD, PhD, MPH
Co-Investigators: Edward J. Hoffenberg, MD and Ronald J. Sokol, MD
Source: National Institutes of Health - DK50979-01
Amount: $111,900/yr
Term: 1996-2000
Hepatobiliary Disease in Cystic Fibrosis - Diagnosis
Principal Investigator: Kenneth Setchell, PhD
Site Director: Michael R. Narkewicz, MD
Source: Cystic Fibrosis Foundation
Amount: $12,000/yr
Term: 1997-1999
Tauro-Ursodeoxycholic Acid for the Treatment of Hepatobiliary Disease in Cystic Fibrosis
Principal Investigator: Kenneth Setchell, PhD
Site Director: Michael R. Narkewicz, MD
Source: Federal Drug Administration
Amount: $5,027
Term: 1997-2000
First Year Clinical Fellowship Award for Robert Kramer, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $36,000
Term: 1998-1999
Second Year Clinical Fellowship Award for Robert Kramer, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $38,000
Term: 1999-2000
Second Year Clinical Fellowship for Edwin Liu, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $40,000
Term: 2000-2001
First and Second Year Clinical Fellowship Award for Gregory Koback, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $36,000
Term: 2000-2002
Second Year Clinical Fellowship Award for Baruch Yerushalmi, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $38,000
Term: 1998-1999
Third Year Research Fellowship Award for Baruch Yerushalmi, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $54,223
Term: 1999-2000
American Liver Foundation Evelyn and James Silver Memorial Fellowship for Baruch Yerushalmi, MD
Principal Investigator: Ronald J. Sokol, MD
Source: American Liver Foundation
Amount: $10,000
Term: 1999-2000
Fourth Year Research Fellowship Award for Andrew Feranchak, MD
Principal Investigator: Ronald J. Sokol, MD
Source: Cystic Fibrosis Foundation
Amount: $48,000
Term: 1998-1999
Oxidant Hepatic Injury in Cholestasis
Principal Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - DK38446-09
Amount: $1,006,612
Term: 1997-2001
A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety and Efficacy of 52 Weeks Lamivudine Treatment at a Dose of 3 mg/kg in Pediatric Subjects with Chronic Hepatitis B
Site Director: Ronald J. Sokol, MD
Source: Glaxo/Wellcome
Amount: $36,378
Term: 1998-2000
North American Society for Pediatric Gastroenterology and Nutrition - World Congress of Pediatric Gastroenterology
Principal Investigator: Harland Winter, MD
Co-Investigator: Ronald J. Sokol, MD
Source: National Institutes of Health - R13 DK58427
Amount: $40,000
Term: 2000
|
|
